NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Medical Patents Alert Section

3DIcon Files International Patent Applications for CSpace®



March 16th, 2009

   2009 MAR 16 -- 3DIcon Corporation (OTCBB:TDCP), a development-stage technology company, announced it has submitted patent applications for its breakthrough 3D imaging technology - CSpace® - in Japan and with the European Patent Office, which covers 32 countries.

   The proprietary 3D display system - CSpace - provides true, single-color, high-resolution, 360-degree, three-dimensional images without any viewing aids. It is the first proven technology of its kind that has no mechanical moving parts. 3D imaging systems developed using CSpace will have the potential to increase accuracy in real-time decision-making and can potentially expedite procedures in multiple applications. The Company recently initiated a commercial marketing effort targeted at both domestic and international companies to introduce the capabilities that the C-Space system can provide.

   “Our CSpace display technology has multiple applications in a wide range of industries, both domestically and internationally,” said Martin Keating, 3DIcon chairman and CEO. “It has the potential to revolutionize the ways in which people visualize images. This technology can provide true 360-degree single-color volumetric images, which no other system has been able to attain. There are potentially major applications in fields such as healthcare and security, and we are moving aggressively to introduce the CSpace system to these industries and others.” About 3DIcon Corporation 3DIcon Corporation (the “Company”) is a developer of groundbreaking 3D projection and display technologies that are being designed to produce full color, 360° volumetric images. The Company recently completed a working prototype of its flagship technology, CSpace®, a breakthrough in 3D imaging, along with concluding a key licensing deal for the CSpace technology. 3DIcon has also launched its first software product, Pixel Precision®, which targets the R&D market for developers using Texas Instruments' DLP® line of products.

   SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995

   Keywords: Business, Diagnosis, Diagnostics, Patent Actions, Patents Actions, 3DIcon Corporation.

   This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

Return to Medical Patents Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login